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Abstract
Background: Chronic complications are the major outcome of type 2 diabetes mellitus progress, which reduce the 
quality of life of patients, incur heavy burdens to the health care system, and increase diabetic mortality. The aims of 
this study were to describe the prevalence of chronic complications among urban Chinese type 2 diabetic outpatients; 
and to analyze the associations between chronic complications and patients' demographics, diabetic related clinical 
characteristics.
Methods: This cross-sectional hospital-based study was carried out in 4 major Chinese cities: - Shanghai, Chengdu, 
Beijing and Guangzhou. The survey was conducted from March to July in 2007 among 1,524 type 2 diabetic 
outpatients. The subjects were interviewed face-to-face by trained interviewers using a questionnaire to capture 
information on demographics, disease presentations and complications. All the subjects were invited to have a HbA1c 
test free of charge by the standardized method with Bio-Rad Variant II.
Results: Of the 1,524 study subjects, 637 (41.8%) were male, and the mean age was 63.3 ± 10.2 years. At least one 
chronic complication was diagnosed in 792 individuals (52.0%) of the study subjects; 509 (33.4%) presented with 
macrovascular complications and 528 (34.7%) with microvascular complications. The prevalence of cardiovascular and 
cerebrovascular conditions, neuropathy, nephropathy, ocular lesions and foot disease were 30.1%, 6.8%, 17.8%, 10.7%, 
14.8% and 0.8%, respectively. The prevalence of chronic complications varied between cities, and significantly 
increased with age and duration of diagnosed diabetes. The mean of HbA1c in diabetic patients with chronic 
complications was 8.2% ± 1.6% and 63.0% of the subjects with type 2 diabetes related complications had a poor 
glycemic control with the HbA1c > 7.5%.
Conclusions: Chronic complications are highly prevalent among type 2 diabetic outpatients, the glycemic control of 
diabetic patients with chronic complications was poor, and future efforts should be directed at intensive blood glucose 
control, strengthening early diagnosis and improving case management to prevent and minimize the occurrence of 
complications.
Introduction
Globally, type 2 diabetes mellitus (T2DM) has become
one of the most important chronic public health prob-
lems[1]. T2DM is a growing cause of disability and pre-
mature death, mainly through cardiovascular disease and
other chronic complications[1-3]. It is estimated that the
global number of adults suffering from any form of diabe-
tes will reach 285 million in 2010 and further increase to
439 million in 2030, most of them T2DM cases[4,5].
China had an estimated 23.8 million diabetics in 2003,
more than 92 million adults with diabetes as it was
reported in 2010, and is considered one of the countries
with the largest T2DM burden[1,6].
Data from prospective and cross-sectional studies con-
sistently point to the fact that diabetic patients are more
likely to develop micro- as well as macro-vascular condi-
tions[7-9]. Prior to the onset of diabetes, many patients
already show metabolic abnormalities, such as dyslipi-
demia, further contributing to the development of com-
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plications[8]. About 50% of the subjects of UKPDS had
substantial macro- or micro-vascular abnormalities at the
time of T2DM diagnosis[9]. It is well known that chronic
complications are the major outcome of T2DM progress,
which reduce the quality of life of patients, incur heavy
burdens to the health care system, and increase diabetic
mortality [10-12]. After adjusting for age, the death rate
of people with T2DM is about twice as high as their non-
diabetic peers[13]. About 50-80% of all individuals with
diabetes die of cardiovascular disease, with cerebrovascu-
lar disease, and kidney failure also among the leading
causes of death[1,13]. Permanent disability is a common
outcome of diabetes, with late complications of diabetes
being major determinants for disability. Diabetic eye dis-
ease, particularly retinopathy, has become a major cause
of blindness throughout the world[1,14]. Moreover, clini-
cal epidemiologic studies suggest that foot ulcers precede
more than 85% of non-traumatic lower extremity ampu-
tations (LEAs) in diabetic individuals[15].
Access to diabetic care is limited in low and middle
income countries (including China) where more than
70% of diabetic patients live [16]. As a transitional society,
China is facing a rapid rise of the T2DM population
accompanying its remarkable economic development,
especially in urban populations. Yet, few studies have
addressed the extent of the T2DM epidemic, as well as
the disease burden of diabetic complications to China's
health care system. It is obvious that information on
prevalence of T2DM related complications is important
for the adjustment of policies and practices in diabetic
care management to gain better control of T2DM. The
a i m s  o f  t h i s  s t u d y  w e r e  t o  d e s c r i b e  t h e  p r e v a l e n c e  o f
chronic complications among urban Chinese T2DM out-
patients; and to analyze the associations between chronic
complications and patients' demographics, T2DM related
characteristics.
Methods
Study population, recruitment and data collection
This cross-sectional study was carried out in 4 major
Chinese cities representing the east, west, north and
south of mainland China: Shanghai, Chengdu, Beijing
and Guangzhou, respectively. Fifteen general hospitals
with endocrinology departments offering specialized dia-
betes care were selected purposively according to the ser-
vice coverage, capacity in treating diabetes and
participation intention of the hospitals, with three to six
in each city. The outpatients were consecutively recruited
in each hospital. All T2DM outpatients fulfilling the
inclusion criteria detailed below and attending the study
facilities during the period March - July 2007 were invited
to participate in the study.
The inclusion criteria were: (1) T2DM diagnosed in
accordance with international standards (WHO 1999),
i.e. fasting plasma glucose (FPG) ≥ 7.0 mmol/L and/or 2
hours postprandial plasma glucose (PPG) or casual
plasma glucose ≥ 11.1 mmol/L[17]; (2) under regular
anti-diabetic drug treatment for at least 1 year; (3) ≥ 18
years old; (4) resident in the respective city for ≥ 2 years;
(5) provided written informed consent to participate in
the study.
Detailed information regarding the study procedures
was provided to all eligible individuals. Only patients who
agreed to participate and signed the consent form were
included in the study. For those refused to participation,
no further information was collected. The subjects were
interviewed face-to-face by trained interviewers using a
questionnaire to capture information on demographics,
diabetic related characteristics and complications. Infor-
mation on diagnosis of diabetic complications including
the location, time and details of the diagnosis was col-
lected. The diagnosis of diabetic complications was
checked with patients' medical charts, and confirmed by
doctors during the investigation. All subjects were asked
to have a HbA1c test free of charge. The blood samples of
5  μ l  w e r e  s e n t  t o  t h e  a s s i g n e d  c e n t e r  i n  e a c h  c i t y  f o r
HbA1c test using the unique procedure with Bio-Rad
Variant II. The level of glycemic control was defined as
optimal (HbA1c < 6.5%), fair (6.5% ≤ HbA1c ≤ 7.5%), and
poor (HbA1c > 7.5%)[18].
This study was approved by the Institutional Review
Board of School of Public Health, Fudan University
(Approval No: #06-12-0065). Written informed consent
was received from all the subjects.
Complications
Only chronic complications (categorized as cardiovascu-
lar conditions, cerebrovascular conditions, nephropathy,
ocular lesions, neuropathy, and diabetic foot problems)
that developed after the proper diagnosis of T2DM and
could be attributed to diabetes were considered in this
study. Cardiovascular morbidity included: hypertension,
angina, chronic heart failure, myocardial infarction, other
related heart diseases, and peripheral vascular disease;
the considered cerebrovascular conditions were stroke
and transient ischemic attack (TIA); ocular lesions con-
sisted of retinopathy, cataract and blindness; nephropa-
thy included microalbuminuria, macroalbuminuria, renal
hypofunction, and renal failure; and diabetic foot prob-
lems presented as foot ulcers or amputation (AMP).
According to the involved blood vessels, complications
were also stratified into macrovascular complications (all
cardiovascular, cerebrovascular and foot diseases) and
microvascular complications (nephropathies, neuropathy
and eye lesions)[19].Liu et al. Health and Quality of Life Outcomes 2010, 8:62
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Data management and statistical analysis
All questionnaire data was double-entered and cross-vali-
dated using EpiData version 3.1 (EpiData Association,
Odense, Denmark). Statistical analyses were performed
in SAS version 6.1 (SAS Institute Inc., Cary, USA). Con-
tinuous variables were summarized with mean and
median, and categorical variables as percentages. Pearson
and trend χ2-tests were used to explore associations in
categorical and ordinal data, respectively. Student's t-test
was used to compare two means in numerical data. Two-
tailed tests were performed with the significance level at
0.05. Generalized linear modeling was employed to esti-
mate the age-adjusted prevalence of complications by
time since the first diagnosis of diabetes, and the linear
relationship between prevalence of complications and
diabetes duration.
Results
General characteristics of study subjects
Overall, a total of 1,524 diabetic individuals were eligible
in the study, 373 were recruited in Shanghai, 375 in Bei-
jing, 376 in Guangzhou and 400 in Chengdu. Among
them were 637 (41.8%) males and 887 (58.2%) females
with a mean age of 63.3 years (range: 18 - 88 years). The
mean of time span between the diagnosis of T2DM and
enrolment in the study was 8.7 years (median: 7.2 years,
25-75th percentile: 3.2-12.5 years).
Prevalence of chronic complications
Overall, 732 of the 1,524 T2DM subjects (48.0%) had no
recognized complications while 792 (52.0%) suffered
from at least one diagnosed chronic complication. The
categorized prevalence of the chronic conditions is pre-
sented in Table 1, along with the prevalence of multiple
complications. The prevalence of cardiovascular and
cerebrovascular complications, neuropathy, nephropathy,
ocular lesions and diabetic foot disease were 30.1%, 6.8%,
17.8%, 10.7%, 14.8% and 0.8%, respectively. The most
prominent cardiovascular condition was angina (14.2%),
and 5.1% of subjects having cardiovascular condition had
two or more conditions. Cerebrovascular complications
included 37 cases of stroke, 54 subjects with TIA and 12
individuals suffering both conditions. Of the 162 subjects
with nephropathy conditions, 107 had single microalbu-
minuria, 10 had microalbuminuria and other concurrent
nephropathy co-morbidities. A total of 225 subjects suf-
fered from ocular complications, with the most promi-
nent conditions being cataract (9.8%) and retinopathy
(6.1%). Foot complications were found among 12 sub-
jects: 10 cases of foot ulcer and 2 individuals who had
undergone AMP.
With regard to the prevalence of chronic complications
of T2DM across categories (organ or system), 465(30.5%)
of the 1,524 subjects had single-category complications
while there were 234 (15.4%), 74 (4.9%) and 19 (1.3%) had
complications across 2, 3 and 4 plus categories respec-
tively (Table 1). Among the entire study subjects, 33.4%
(males: 31.1%; females: 35.1%) had at least one macrovas-
cular complication and 34.7% (males: 28.9%; females:
38.8%) had at least one microvascular complication.
Geographic and demographic stratification of chronic 
complications
Table 2 shows the prevalence of chronic T2DM complica-
tions, stratified by demographic and geographic vari-
ables. The overall prevalence of complications among
female subjects was significantly higher than in male sub-
jects (χ2 = 9.75, p = 0.002), most notably in neuropathy (χ2
= 12.73, p < 0.001) and eye diseases (χ2 = 6.23, p = 0.013).
The prevalence of complications also varied between
subjects from different regions of China (χ2 = 8.763, p =
0.033). Higher prevalence of cardio- and cerebrovascular
conditions were noted in subjects from Beijing and
Guangzhou. Both the overall prevalence of complications
(χ2
trend = 91.90, p < 0.001) and the prevalence of all con-
sidered conditions increased with age (p-values < 0.05).
Association between chronic complications and T2DM 
duration
Figure 1 shows the age-adjusted prevalence of vascular
morbidities by time since T2DM had been diagnosed.
After adjusting for age, the overall prevalence of compli-
cations significantly increased with disease duration (χ 2 =
106.290, p < 0.001). Cardiovascular disease (χ 2 = 42.411,
p < 0.001), neuropathy (χ 2 = 36.226, p < 0.001), eye dis-
ease (χ 2 = 107.069, p < 0.001) and renopathy (χ 2 = 21.537,
p < 0.001) were significantly associated with disease dura-
tion. Cerebrovascular morbidity (χ 2 = 5.103, p = 0.024)
also showed a significant increase with diabetes duration,
but the overall increase in prevalence was low compared
to the other conditions investigated here.
Status of glycemic control in subjects with chronic 
complications of T2DM
Of the 1511 subjects completing HbA1c tests, the average
level of HbA1c for the 784 with chronic complications
was 8.2% (ranging from 4.7% to 14.5%), whereas it was
8.0% (ranging from 4.4% to 16.7%) for the 727 without
chronic complications (t = 2.429, P = 0.015). Of subjects
with chronic complications, 12.1% meet the optimal tar-
gets of HbA1c < 6.5%, while 63.0% had poor glycemic
control with their HbA1c > 7.5%. Results for HbA1c of
diabetic subjects categorized by chronic complications
are shown in Table 3.
Discussion
Considering the significant impact of chronic complica-
tions on T2DM-related morbidity and mortality, and theLiu et al. Health and Quality of Life Outcomes 2010, 8:62
http://www.hqlo.com/content/8/1/62
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Table 1: Prevalence of chronic complications among 1,524 urban Chinese T2DM outpatients, categorized by organ and 
system
Categories by organ and system No. of individuals %
Cardiovascular conditions 459 30.1
1 cardio-condition 381 25.0
Angina 161 10.6
Hypertension 130 8.5
Chronic heart failure 45 3.0
Heart disease 16 1.0
Infarction 12 0.8
Percutaneous transluminal coronary angioplasty 11 0.7
Peripheral vascular disease 6 0.4
2 cardio-conditions concurrently 70 4.6
Angina + other cardio-conditions 47 3.1
Other 2 cardio-conditions concurrently 23 1.5
3 cardio-conditions concurrently 8 0.5
Angina+ other cardio-conditions 8 0.5
Cerebrovascular conditions 103 6.8
1 cerebro-condition 91 6.0
Stroke 37 2.4
Transient ischemic attack(TIA) 54 3.6
Both stroke and TIA 12 0.8
Neuropathy 271 17.8
Nephropathy conditions 162 10.7
1 nephro-condition 152 10.0
Microalbuminuria 107 7.0
Macroalbuminuria 12 0.8
Renal hypofunction 4 0.3
Renal failure 29 1.9
2 nephro-conditions concurrently 10 0.7
Microalbuminuria + other nephro-condition 10 0.7
Ocular conditions 225 14.8
1 ocular condition 205 13.5
Cataract 131 8.6
Retinopathy 73 4.8
Blindness 10 . 1
2 ocular conditions concurrently 20 1.3
Cataract + Retinopathy 19 1.2
Retinopathy + Blindness 1 0.1
Foot diseases 12 0.8
Foot ulcer 10 0.7
Amputation(AMP) 2 0.1
Single category 465 30.5
2 category concurrently 234 15.4
3 category concurrently 74 4.9
4 plus category concurrently 19 1.3
Total 792 52.0L
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Table 2: Distribution of chronic complications in different socio-demographic groups among 1,524 urban Chinese T2DM outpatients
Variables n Cardiovascular Cerebrovascular Neuropathy Retinopathy Eye disease Foot disease Overall
n (%) n (%) n (%) n (%) N (%) n (%) n (%)
Sex
Male 637 181 (28.4) 39 (6.1) 87 (13.7) 60 (9.4) 77 (12.1) 6 (0.9) 301 (47.3)
Female 887 278 (31.3) 64 (7.2) 184 (20.7) 102 (11.5) 148 (16.7) 6 (0.7) 491 (55.4)
χ2 = 1.51 χ2 = 0.70 χ2 = 12.73 χ2 = 1.69 χ2 = 6.23 χ2 = 0.33 χ2 = 9.75
p = 0.219 p = 0.402 p < 0.001 p = 0.194 p = 0.013 p = 0.563 p = 0.002
City
Beijing 375 115 (30.7) 31 (8.3) 57 (15.2) 45 (12.0) 63 (16.8) 2 (0.5) 207 (55.2)
Guangzho
u
376 148 (39.4) 31 (8.2) 82 (21.8) 39 (10.4) 42 (11.2) 3 (0.8) 211 (56.1)
Shanghai 373 79 (21.2) 26 (7.0) 58 (15.5) 39 (10.5) 52 (13.9) 2 (0.5) 175 (46.9)
Chengdu 400 117 (29.3) 15 (3.8) 74 (18.5) 39 (9.8) 68 (17.0) 5 (1.3) 199 (49.8)
χ2 = 29.62 χ2 = 8.44 χ2 = 7.29 χ2 = 1.11 χ2 = 6.88 χ2 = 1.71 χ2 = 8.76
p < 0.001 p = 0.038 p = 0.063 p = 0.776 p = 0.076 p = 0.635 p = 0.033
Age (years)
< 50 147 16 (10.9) 1 (0.7) 8 (5.4) 8 (5.4) 8 (5.4) - 33 (22.4)
50 ~ 391 108 (27.6) 23 (5.9) 36 (9.2) 41 (10.5) 50 (12.8) 1 (0.3) 176 (45.0)
60 ~ 552 174 (31.5) 40 (7.2) 105 (19.0) 60 (10.9) 72 (13.0) 5 (0.9) 294 (53.3)
70 ~ 434 161 (37.1) 39 (9.0) 122 (28.1) 53 (12.2) 95 (21.9) 6 (1.4) 289 (66.6)
χ2
trend = 32.30 χ2
trend = 11.09 χ2
trend = 65.49 χ2
trend = 3.95 χ2
trend = 25.62 χ2
trend = 4.54 χ2
trend = 91.90
p < 0.001 p = 0.001 p < 0.001 p = 0.047 p < 0.001 p = 0.033 p < 0.001Liu et al. Health and Quality of Life Outcomes 2010, 8:62
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resulting pressure on health care resources[20,21], under-
standing the epidemiology of T2DM co-morbidities is of
great importance. Over the last two decades, there have
been only a handful of small-scale studies dealing with
the prevalence of chronic complications among diabetic
outpatients in China[22-25]. Most of them were con-
ducted in a single hospital or city and had a limited sam-
ple size. Only one study carried out in 2002 in 11 cities
across China boasted a large sample size of 4,225 T2DM
using both in- and outpatients[26]. It should be noted,
however, that in this study, data concerning complica-
tions was reported by the 200 designated endocrinolo-
gists according to their patients' prescriptions. Also, the
prevalence of complications among outpatients was not
described[26].
The present multi-center study exclusively targeted
T2DM outpatients. The 1,524 individuals with T2DM
finally included in this study were recruited from the out-
patient department (OPD) of 15 general hospitals in four
major cities of mainland China. The findings derived
from this study can, thus, be expected to a large extent
represent the prevalence of T2DM-related chronic mor-
bidity among the respective outpatients in urban main-
land China. We found that complications are highly
prevalent among urban mainland Chinese T2DM outpa-
tients. Overall, more than half of the individuals included
in this study suffered from at least one chronic complica-
tion, and almost one-quarter of them were afflicted by 2
or more categorized conditions. Given the estimated 23.8
million diabetic patients across China, as reported by the
International Diabetes Federation and that 95% of these
cases are of type 2[1], it must be assumed that there are
11-12 million T2DM patients suffering from at least one
diabetic co-morbidity across mainland China, and that
about 6 million simultaneously suffer from more than
one co-morbidity. Thus, chronic complications of T2DM
exert a huge burden on China's health care system. The
overall prevalence of macrovascular complications
(33.4%) noted in the present study is somewhat lower
than the corresponding rates reported from Oklahoma,
Warsaw, Havana, Berlin and Australia, but is higher than
the rates reported in previous studies conducted in
China[27-29]. The overall prevalence of microvascular
complications found in this study (34.7%) is higher than
both the pooled rates in the WHO Multinational Study of
Vascular Disease in Diabetes (WHO MSVDD), in Austra-
lia and in other studies from China[27-29]. This suggests
t h a t  t h e  T 2 D M  p a t i e n t s  i n c l u d ed  i n  o u r  s t u d y  h a d  a n
above-average rate of vascular complications. Microvas-
cular conditions in particular markedly increased over
time since diabetes had been diagnosed. As a result, the
estimated case burden of T2DM-related macro- and
microvascular complications across mainland China
could be as high as 8 million[1].
This study also found a predominance of cardiovascu-
lar conditions among T2DM patients in China over other
morbidities. Studies carried out among British outpa-
tients as well as Chinese inpatients also pointed to cardio-
vascular conditions as the predominant chronic
complication of T2DM[30,31]. Therefore, effective mea-
sures for the prevention of cardiovascular complications
are essential for reducing overall morbidity due to diabe-
tes. Neuropathy, with a prevalence of 17.8%, was some-
what less common in this study than in studies carried
out in Canada, the United States and Sweden[32-34]. The
prevalence was also about 4% lower than in another study
conducted among urban Chinese patients in 2002[26].
The most surprising finding was the low prevalence of
foot diseases at 0.8%, much lower than the 8.0% reported
for Asian-Americans[35]. However, it should be noted
that the criteria employed to establish foot disease dif-
fered between the two studies. In the present study, foot
disease was established through a doctor's diagnosis,
whereas the previously mentioned study relied on self-
reported symptoms[35]. In China, even low prevalence
translates into substantial absolute disease burden figures
due to the high number of diabetic patients. For example,
the number of T2DM patients suffering from foot disease
(the least prevalent chronic complication according to
Figure 1 Age-adjusted prevalence of chronic complications of 
T2DM in 1524 urban Chinese T2DM outpatients by diabetic dura-
tion.Liu et al. Health and Quality of Life Outcomes 2010, 8:62
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this study) could be as high as 200,000. This underscores
the need for effective programs for screening, preventing
and treating diabetic complications.
Both gender and resident location were found to be sig-
nificantly associated with the prevalence of chronic com-
plications among urban T2DM outpatients in mainland
China. Gender, economic differences, variations in life-
style and unequal health care system performance may
each contribute to the observed differences[36]. Varia-
tions are substantial in different cities of China. Take Bei-
jing and Shanghai as examples: people in North China
such as Beijing are taller, larger than people in south and
east China, and also food in north China is saltier and
heavier than those in Shanghai[37]. There are also other
differences such as housing, climate, lifestyles (smoking,
drinking, etc.), coverage of medical insurance, etc. Such
variations and their impacts should be further explored in
studies on chronic complication of diabetes to allow tai-
loring interventions to effectively respond to local needs.
The higher prevalence of microvascular complications
including neuropathy and eye disease among female dia-
betic patients corresponds to earlier findings reported in
the literature[38,39]. Hormones and factors associated
w i t h  o c c u p a t i o n a l  a n d  s o c i a l  i n e q u a l i t i e s  h a v e  b e e n
invoked as tentative explanations. With regard to the pre-
vention, management and treatment of neuropathy and
eye disease, this suggests that special attention should be
paid to female diabetic patients.
The prevalence of the investigated chronic diabetic
complications was found to increase with age. This is
consistent with the results of other studies[30,39,40], and
the prevalence of complications was positively associated
with the duration of disease, irrespective of the patients'
age. Due to the limitations of the cross-sectional study on
causation, we cannot infer that duration of diabetes is a
risk factor for chronic complications. But the results do
point out that much more attention on prevention for
diabetic chronic complications should be paid to diabetic
patients with longer disease duration. To gain a better
control of chronic complications, treatment and manage-
ment for T2DM complications in urban Chinese popula-
tions should primarily target the highly prevalent
populations with chronic complications including older
diabetic patients and those with a long history of diabe-
tes.
The incidence of chronic complications in T2DM
patients was significantly associated with the degree of
hyperglycemia, as measured by the plasma glucose or the
HbA1c level. According to a cohort study, a 1% reduction
in average HbA1c was associated with reductions of 14%
for myocardial infarction and 37% for microvascular
complications[41]. This study found that 63.4% of the
diabetic patients with chronic complications had poor
HbA1c control. Although through a cross-sectional
study, we could not conclude that poor glycemic control
results in chronic complications, it still triggers a warning
to the health authority that there is an urgent need for
glycemic management, and the chronic complications of
T2DM will worsen under current glycemic status.
Since the present study was hospital-based and the sub-
jects were enrolled in the settings of general hospitals in
major cities of China, its results only apply for T2DM-
related chronic complications in the population frequent-
ing urban mainland Chinese health-care institutions.
Therefore the findings are valid for patients managed by
hospitals rather than the general diabetic population.
Considering that patients who do not frequent the OPD
are most likely to be healthier than their peers who were
included in this study, the study possibly overestimates
the true prevalence of chronic T2DM-related complica-
Table 3: The glycemic control in diabetic patients with and without chronic complications
T2DM chronic complications* HbA1c
Mean ± SD(%) < 6.5%(%) 6.5%-7.5%(%) > 7.5%(%)
Without chronic conditions(n = 727) 8.0 ± 1.6 111 (15.3) 213(29.3) 403(55.4)
With chronic conditions(n = 784) † 8.2 ± 1.6 95 (12.1) 195(24.9) 494(63.0)
Cardiovascular conditions(n = 457) 8.0 ± 1.5 64(14.0) 121(26.5) 272(59.5)
Neuropathy(n = 268) 8.0 ± 1.6 40(14.9) 66(24.6) 162(60.4)
Cerebrovascular conditions(n = 103) 8.2 ± 1.7 16(15.5) 23(22.3) 64(62.1)
Nephropathy conditions(n = 160) 8.3 ± 1.7 19(11.9) 34(21.3) 107(66.9)
Ocular conditions(n = 221) 8.6 ± 1.7 19(8.6) 43(19.5) 159(71.9)
Foot diseases(n = 12) 8.1 ± 2.0 3(25.0) 3(25.0) 6(50.0)
*: Results of HbA1c tests were not available for five patients without chronic conditions and 8 with complications.
†: Patients with multiple category conditions were counted repeatedly under each category.Liu et al. Health and Quality of Life Outcomes 2010, 8:62
http://www.hqlo.com/content/8/1/62
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tions among the diagnosed T2DM outpatients in main-
land China. One of the limitations of the study is that
purposive sampling was applied instead of random sam-
pling. Service coverage, capacity in treating T2DM and
participation intention were taken into account for sam-
pling. The selected hospitals were all tertiary or second-
ary hospitals with specialized department for diabetes,
where majority of T2DM patients under treatment vis-
ited. However, the purposive sampling could still affect
the impacts of the study, especially for generalization.
Another limitation of the study is that we do not have the
information on patients who reject to participation. To
increase the response, our data collectors waited outside
the consultation room, and invited patients consecutively
for the interview after they completed the consultation
with doctors. Although very few patients rejected to par-
ticipation, bias might be incurred to some extent.
Conclusions
The present study provides detailed estimates of the
prevalence of T2DM-related chronic complications
among outpatients in 4 major urban cities across main-
land China. Thus, the results are relevant for the preven-
tion, management and treatment of chronic T2DM-
related complications in urban mainland China. A high
prevalence of chronic complications was found among
outpatients with T2DM, with a predominance of cardio-
vascular and neuropathic conditions. It is worth noting
that a high proportion of T2DM outpatients suffered
from two or more categorized conditions concurrently.
The mean level of HbA1c in diabetic patients with
chronic complications was 8.2% and 63.0% of the patients
with T2DM-related complications having a poor glyce-
mic control with their HbA1c > 7.5%. The results suggest
that policy and strategy aimed at the management of gly-
cemic control and prevention of T2DM complications
should be put forward, and that the management of
T2DM patients must not be neglected. The increase of
complications with age and time since T2DM diagnosis,
as well as geographic variation, all point to a need for
flexible and adaptive approaches for the prevention and
management of T2DM cases in order to allocate medical
resources efficiently and according to the true local bur-
den of disease due to T2DM complications.
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